Immune System Uses Gut Bacteria To Control Glucose Metabolism

Immune System Uses Gut Bacteria To Control Glucose Metabolism

Article
Digestive Health
Nutrition & Dietetics
+2
Contributed byMaulik P. Purohit MD MPHNov 22, 2016

Researchers at Oregon State University and other institutions have discovered an important link between the immune system, gut bacteria and glucose metabolism -- a "cross-talk" and interaction that can lead to type 2 diabetes and metabolic syndrome when not functioning correctly.

The findings, published in Nature Communications, are one example of how different mammalian systems can affect each other in ways not previously understood.

A better understanding of these systems, researchers say, may lead to new probiotic approaches to diabetes and other diseases.

The research also shows the general importance of proper bacterial functions in the gut and the role of one bacteria in particular -- Akkermansia muciniphila -- in helping to regulate glucose metabolism.

This bacteria's function is so important, scientists say, that it has been conserved through millions of years of evolution to perform a similar function in both mice and humans.

"We're discovering that in biology there are multiple connections and communications, what we call cross-talk, that are very important in ways we're just beginning to understand," said Dr. Natalia Shulzhenko, an assistant professor in the OSU College of Veterinary Medicine, and one of the corresponding authors on this study.

"It's being made clear by a number of studies that our immune system, in particular, is closely linked to other metabolic functions in ways we never realized. This is still unconventional thinking, and it's being described as a new field called immunometabolism. Through the process of evolution, mammals, including humans, have developed functional systems that communicate with each other, and microbes are an essential part of that process."

It had been previously observed that an immune mediator -- one type of interferon, or signaling protein called IFN-y -- can affect the proper function of glucose metabolism. IFN-y helps fight several pathogens and infections, but a decrease in its levels can lead to improvement in glucose metabolism. However, this actual process has not been understood.

"Before this, no one had a clue exactly how IFN-y affected glucose tolerance," said Andrey Morgun, an assistant professor in the OSU College of Pharmacy and also a corresponding author on the study. "The involvement of microbes had not really been considered. But with the help of a statistical model and an approach we call a transkingdom network, we were able to pinpoint some likely bacterial candidates."

The bacteria A. muciniphila, was found to play a critical role in this communication process -- in their study, the scientists called it a "missing link." Research showed that mice specially bred with reduced levels of IFN-y had higher levels of A. muciniphila, and significantly improved glucose tolerance. When IFN-y levels increased, A. muciniphila levels declined, and glucose tolerance was reduced.

Similar observations were also made in humans. It's been observed, for instance, that athletes who are extremely fit have high levels of the gut bacteria A. muciniphila, which is a mucus-degrading bacteria. The research makes clear that two systems once believed to be functionally separate -- immunity and glucose metabolism -- are, in fact, closely linked, and the bridge can be provided by gut bacteria.

There's probably more than one bacteria involved in this process of communication and metabolic control, researchers said. The gut harbors literally thousands of microbes that appear to function almost as a metabolically active organ, emphasizing the critical importance of gut bacterial health.

Bacteria-mediated communication, of course, is just one part of complex human systems -- issues such as proper diet, exercise, and appropriate weight control are all still important, the researchers said.



Materials provided by Oregon State UniversityNote: Content may be edited for style and length.

Disclaimer: DoveMed is not responsible for the adapted accuracy of news releases posted to DoveMed by contributing universities and institutions.

Primary Resource:

Greer, R. L., Dong, X., Moraes, A. C. F., Zielke, R. A., Fernandes, G. R., Peremyslova, E., ... & Ferreira, S. R. (2016). Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism. Nature Communications7, 13329.

Was this article helpful

On the Article

Maulik P. Purohit MD MPH picture
Approved by

Maulik P. Purohit MD MPH

Assistant Medical Director, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!